Pubblicazioni

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: is BRCA mutational status making the difference?

2022 - CANCER TREATMENT AND RESEARCH COMMUNICATIONS
Ghirardi, Valentina; De Felice, Francesca; D'Indinosante, Marco; Bernardini, Federica; Giudice, Maria Teresa; Fagotti, Anna; Scambia, Giovanni

First-line treatment with olaparib for early stage BRCA-positive ovarian cancer: May it be possible? Hypothesis potentially generating a line of research

2020 - CANCER MANAGEMENT AND RESEARCH
Tomao, F.; Boccia, S. M.; Chirra, M.; Palaia, I.; Petrella, M. C.; Di Donato, V.; Colombo, N.; Panici, P. B.; Sassu, C. M.

Nipple-sparing bilateral prophylactic mastectomy and immediate reconstruction with TiLoop®Bra mesh in BRCA1/2 mutation carriers: a prospective study of long-term and patient reported outcomes using the BREAST-Q

2018 - THE BREAST
Casella, D.; Di Taranto, G.; Marcasciano, M.; Sordi, S.; Kothari, A.; Kovacs, T.; Lo Torto, F.; Cigna, E.; Ribuffo, D.; Calabrese, C.

Rucaparib. An emerging parp inhibitor for treatment of recurrent ovarian cancer

2018 - CANCER TREATMENT REVIEWS
Musella, Angela; Bardhi, Erlisa; Marchetti, Claudia; Vertechy, Laura; Santangelo, Giusi; Sassu, Carolina; Tomao, Federica; Rech, Francesco; D'Amelio, Renzo; Monti, Marco; Palaia, Innocenza; Muzii, Ludovico; Benedetti Panici, Pierluigi

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma